» Authors » Yohei Kirino

Yohei Kirino

Explore the profile of Yohei Kirino including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 166
Citations 4609
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
21.
Hidekawa C, Yoshimi R, Saigusa Y, Tamura J, Kojitani N, Suzuki N, et al.
Front Immunol . 2023 Sep; 14:1227403. PMID: 37720209
Objectives: Infection is a leading cause of death in patients with systemic lupus erythematosus (SLE). Alt hough hydroxychloroquine (HCQ) has been reported to inhibit infection, evidence from Asian populations remains...
22.
Maeda A, Tsuchida N, Uchiyama Y, Horita N, Kobayashi S, Kishimoto M, et al.
Rheumatology (Oxford) . 2023 Aug; 63(8):2056-2064. PMID: 37606963
Objectives: To efficiently detect somatic UBA1 variants and establish a clinical scoring system predicting patients with pathogenic variants in VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome. Methods: Eighty-nine Japanese...
23.
Hirahara Y, Yamaguchi M, Takase-Minegishi K, Kirino Y, Aoki S, Hirahara L, et al.
Rheumatology (Oxford) . 2023 Aug; 63(2):277-284. PMID: 37594755
Objective: The relationship between FMF and pregnancy outcomes remains unclear. This systematic review and meta-analysis aimed to clarify this association. Methods: Electronic databases-PubMed, Web of Science, Cochrane, and EMBASE-were searched...
24.
Miyoshi Y, Kise T, Morita K, Okada H, Imadome K, Tsuchida N, et al.
Mod Rheumatol Case Rep . 2023 Aug; 8(1):199-204. PMID: 37548220
We herein describe the case of a 52-year-old male patient who presented with fever, arthritis, and neutrophilic dermatosis in 2013 and subsequently experienced macrophage activation syndrome treated with high-dose glucocorticoid...
25.
Hirohata S, Kikuchi H, Sawada T, Kuwana M, Kawachi I, Kirino Y, et al.
Intern Med . 2023 Jun; 63(4):481-486. PMID: 37344428
Objectives Chronic progressive neuro-Behcet's disease (CPNB) is characterized by progressive deterioration leading to disability. Methotrexate (MTX) has been shown to have beneficial effects on CPNB. However, while infliximab has been...
26.
Ohashi T, Takase-Minegishi K, Maeda A, Hamada N, Yoshimi R, Kirino Y, et al.
J Hematol . 2023 May; 12(2):66-74. PMID: 37187501
Background: Immune checkpoint inhibitors (ICIs) have been a breakthrough in cancer therapy. ICI therapy is generally better tolerated than cytotoxic chemotherapy; however, hematological adverse events (AEs) have not been fully...
27.
Teshigawara T, Meguro A, Takeuchi M, Ishido M, Soejima Y, Hirahara L, et al.
Ocul Immunol Inflamm . 2023 May; 32(4):447-453. PMID: 37133403
Purpose: To investigate whether polymorphisms of and , which each encode protein ligands for a family of tyrosine kinase receptors, are associated with Behçet's disease (BD) in a Japanese population....
28.
Kunimoto H, Miura A, Maeda A, Tsuchida N, Uchiyama Y, Kunishita Y, et al.
Int J Hematol . 2023 Apr; 118(4):494-502. PMID: 37062784
VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome is a new disease entity with autoinflammatory disorders (AID) driven by somatic variants in UBA1 that frequently co-exists with myelodysplastic syndromes (MDS)....
29.
Motegi H, Kirino Y, Morishita R, Nishino I, Suzuki S
Neuromuscul Disord . 2023 Apr; 33(5):405-409. PMID: 37037049
Overlap syndrome is a clinical entity of myositis concomitant with one or more collagen diseases such as systemic lupus erythematosus, systemic sclerosis, and/or rheumatoid arthritis. It is not evident whether...
30.
Nagafuchi H, Kikuchi H, Ishibash H, Maeda H, Ogino H, Kirino Y, et al.
Mod Rheumatol . 2023 Jan; 34(1):182-193. PMID: 36658731
Objectives: This study aimed to develop clinical guidelines for the management of vascular Behçet's disease (BD) by the Behçet's Disease Research Committee of the Ministry of Health, Labour and Welfare...